SB 1315
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Lilly USA | Lobbied on it | Lilly USA named SB 1315 in 4 lobbying reports. | 4 reports |
| Pharmacia | Lobbied on it | Pharmacia named SB 1315 in 4 lobbying reports. | 4 reports |
| Allergan, Inc. and Its Affiliates | Lobbied on it | Allergan, Inc. and Its Affiliates named SB 1315 in 3 lobbying reports. | 3 reports |
| Amgen | Lobbied on it | Amgen named SB 1315 in 3 lobbying reports. | 3 reports |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named SB 1315 in 3 lobbying reports. | 3 reports |
| GSK | Lobbied on it | GSK named SB 1315 in 3 lobbying reports. | 3 reports |
| Healthcare Distribution Alliance (Hda) | Lobbied on it | Healthcare Distribution Alliance (Hda) named SB 1315 in 3 lobbying reports. | 3 reports |
| MC Kesson Corporation | Lobbied on it | MC Kesson Corporation named SB 1315 in 3 lobbying reports. | 3 reports |
| Pharmaceuticals: purchasing. | Source records | SB 1315 has an explicit source reference to Pharmaceuticals: purchasing.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…
